304 related articles for article (PubMed ID: 28955296)
1. Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.
Velázquez-Pérez LC; Rodríguez-Labrada R; Fernandez-Ruiz J
Front Neurol; 2017; 8():472. PubMed ID: 28955296
[TBL] [Abstract][Full Text] [Related]
2. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
[TBL] [Abstract][Full Text] [Related]
3. Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation.
Sen NE; Canet-Pons J; Halbach MV; Arsovic A; Pilatus U; Chae WH; Kaya ZE; Seidel K; Rollmann E; Mittelbronn M; Meierhofer D; De Zeeuw CI; Bosman LWJ; Gispert S; Auburger G
Neurobiol Dis; 2019 Dec; 132():104559. PubMed ID: 31376479
[TBL] [Abstract][Full Text] [Related]
4. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group.
Pujana MA; Corral J; Gratacòs M; Combarros O; Berciano J; Genís D; Banchs I; Estivill X; Volpini V
Hum Genet; 1999 Jun; 104(6):516-22. PubMed ID: 10453742
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of spinocerebellar ataxia type 2 in Cuba.
Velázquez-Pérez L; Rodríguez-Labrada R; García-Rodríguez JC; Almaguer-Mederos LE; Cruz-Mariño T; Laffita-Mesa JM
Cerebellum; 2011 Jun; 10(2):184-98. PubMed ID: 21399888
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.
Geschwind DH; Perlman S; Figueroa CP; Treiman LJ; Pulst SM
Am J Hum Genet; 1997 Apr; 60(4):842-50. PubMed ID: 9106530
[TBL] [Abstract][Full Text] [Related]
9. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
Bäumer D; East SZ; Tseu B; Zeman A; Hilton D; Talbot K; Ansorge O
Acta Neuropathol; 2014 Oct; 128(4):597-604. PubMed ID: 24718895
[TBL] [Abstract][Full Text] [Related]
10. [Advance in research on spinocerebellar ataxia 2].
Jing F; Yang D; Chen T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):284-287. PubMed ID: 29653012
[TBL] [Abstract][Full Text] [Related]
11. A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2.
Scoles DR; Gandelman M; Paul S; Dexheimer T; Dansithong W; Figueroa KP; Pflieger LT; Redlin S; Kales SC; Sun H; Maloney D; Damoiseaux R; Henderson MJ; Simeonov A; Jadhav A; Pulst SM
J Biol Chem; 2022 Aug; 298(8):102228. PubMed ID: 35787375
[TBL] [Abstract][Full Text] [Related]
12. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression.
Canet-Pons J; Sen NE; Arsović A; Almaguer-Mederos LE; Halbach MV; Key J; Döring C; Kerksiek A; Picchiarelli G; Cassel R; René F; Dieterlé S; Fuchs NV; König R; Dupuis L; Lütjohann D; Gispert S; Auburger G
Neurobiol Dis; 2021 May; 152():105289. PubMed ID: 33577922
[TBL] [Abstract][Full Text] [Related]
13. Progression of Cerebellar Atrophy in Spinocerebellar Ataxia Type 2 Gene Carriers: A Longitudinal MRI Study in Preclinical and Early Disease Stages.
Nigri A; Sarro L; Mongelli A; Pinardi C; Porcu L; Castaldo A; Ferraro S; Grisoli M; Bruzzone MG; Gellera C; Taroni F; Mariotti C; Nanetti L
Front Neurol; 2020; 11():616419. PubMed ID: 33384659
[TBL] [Abstract][Full Text] [Related]
14. Prodromal spinocerebellar ataxia type 2: Prospects for early interventions and ethical challenges.
Velázquez-Pérez L; Rodríguez-Labrada R; Laffita-Mesa JM
Mov Disord; 2017 May; 32(5):708-718. PubMed ID: 28256108
[TBL] [Abstract][Full Text] [Related]
15. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
[TBL] [Abstract][Full Text] [Related]
16. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
Costa RG; Conceição A; Matos CA; Nóbrega C
Cell Death Dis; 2024 Jun; 15(6):415. PubMed ID: 38877004
[TBL] [Abstract][Full Text] [Related]
17. Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2.
Pedroso JL; Braga-Neto P; Escorcio-Bezerra ML; Abrahão A; de Albuquerque MV; Filho FM; de Souza PV; de Rezende Pinto WB; Borges FR; Saraiva-Pereira ML; Jardim LB; Barsottini OG
Cerebellum; 2017 Feb; 16(1):34-39. PubMed ID: 26825292
[TBL] [Abstract][Full Text] [Related]
18. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2.
Wang C; Xu Y; Feng X; Ma J; Xie S; Zhang Y; Tang BS; Chan P
Neurobiol Aging; 2015 Jan; 36(1):545.e1-7. PubMed ID: 25189117
[TBL] [Abstract][Full Text] [Related]
19. The Multiple Faces of Spinocerebellar Ataxia type 2.
Antenora A; Rinaldi C; Roca A; Pane C; Lieto M; Saccà F; Peluso S; De Michele G; Filla A
Ann Clin Transl Neurol; 2017 Sep; 4(9):687-695. PubMed ID: 28904990
[TBL] [Abstract][Full Text] [Related]
20. Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration.
Paul S; Dansithong W; Figueroa KP; Scoles DR; Pulst SM
Nat Commun; 2018 Sep; 9(1):3648. PubMed ID: 30194296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
